◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksC › CAH

Cardinal Health Inc (CAH) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Health Care Distributors · DATA UPDATED 2026-09-12

Cardinal Health Inc (CAH) operates in the Health Care Distributors industry and is headquartered in Dublin, United States with about 58,788 employees. Its market capitalization is roughly $52 billion. In the fiscal year ended 2026-06-30, CAH reported $254.2B in revenue and $1.7B in net income.

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution.

Interactive charts & full statements → Open the CAH valuation workbench →

CAH Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302026-06-302025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-30
Total Revenue$254.2B$254.2B$222.6B$226.8B$205.0B$181.3B$162.5B$152.9B$145.5B$136.8B$130.0B$121.5B$102.5B$91.1B$101.1B$107.6B$102.6B$98.5B$96.0B$87.4B$86.9B
Gross Profit$9.8B$9.8B$8.2B$7.4B$6.9B$6.5B$6.8B$6.9B$6.8B$7.2B$6.5B$6.5B$5.7B$5.2B$4.9B$4.5B$4.2B$3.8B$5.5B$5.6B$5.2B
Gross Margin %3.8%3.8%3.7%3.3%3.4%3.6%4.2%4.5%4.7%5.2%5.0%5.4%5.6%5.7%4.9%4.2%4.0%3.8%5.8%6.5%6.0%
Operating Income (EBIT)$2.6B$2.6B$2.3B$1.2B$752M($607M)$472M($4.1B)$2.1B$126M$2.1B$2.5B$2.2B$1.9B$996M$1.8B$1.5B$1.3B$1.3B$1.4B$1.4B
Operating Margin %1.0%1.0%1.0%0.5%0.4%-0.3%0.3%-2.7%1.4%0.1%1.6%2.0%2.1%2.1%1.0%1.7%1.5%1.3%1.3%1.6%1.6%
Net Income$1.7B$1.7B$1.6B$852M$330M($938M)$611M($3.7B)$1.4B$256M$1.3B$1.4B$1.2B$1.2B$334M$1.1B$959M$642M$1.2B$1.3B$1.9B
Net Margin %0.7%0.7%0.7%0.4%0.2%-0.5%0.4%-2.4%0.9%0.2%1.0%1.2%1.2%1.3%0.3%1.0%0.9%0.7%1.2%1.5%2.2%
EBITDA$3.5B$3.5B$3.1B$2.0B$1.4B$55M$1.3B($2.6B)$3.0B$1.1B$2.8B$3.1B$2.6B$2.4B$1.4B$2.1B$1.9B$1.6B$1.6B$1.7B$1.8B
Earnings Per Share (EPS)$7.22$7.23$6.45$3.45$1.26$-3.36$2.08$-12.60$4.53$0.81$4.03$4.32$3.63$3.38$0.97$3.06$2.72$1.78$3.19$3.57$4.77
Shares Outstanding (M)237M237M242M247M262M279M294M293M301M315M320M330M335M345M344M349M352M361M362M364M405M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CAH Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Revenue$63.9B$60.9B$65.4B$64.0B$60.2B$54.9B$55.3B$52.3B
Gross Profit$2.7B$2.5B$2.2B$2.3B$2.2B$2.1B$1.9B$1.9B
Gross Margin %4.3%4.1%3.4%3.6%3.7%3.9%3.5%3.6%
Operating Income (EBIT)$729M$509M$707M$668M$428M$730M$549M$568M
Operating Margin %1.1%0.8%1.1%1.0%0.7%1.3%1.0%1.1%
Net Income$394M$399M$471M$450M$239M$506M$400M$416M
Net Margin %0.6%0.7%0.7%0.7%0.4%0.9%0.7%0.8%
EBITDA$1.1B$741M$707M$911M$667M$946M$738M$755M
Earnings Per Share (EPS)$1.66$1.69$1.99$1.88$1.00$2.10$1.65$1.70
Shares Outstanding (M)237M236M237M239M240M241M243M245M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CAH Free Cash Flow History

Cash flowTTM → 2026-06-302026-06-302025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-30
Cash from Operations (CFO)$5.2B$5.2B$2.4B$3.8B$2.8B$3.1B$2.4B$2.0B$2.7B$2.8B$1.2B$3.0B$2.5B$2.5B$1.7B$1.2B$1.4B$2.1B$1.6B$1.5B$1.2B
Capital Expenditures (CapEx)$649M$649M$547M$511M$481M$387M$400M$375M$328M$384M$387M$465M$300M$249M$195M$263M$291M$256M$533M$376M$357M
Free Cash Flow (FCF)$4.5B$4.5B$1.9B$3.3B$2.4B$2.7B$2.0B$1.6B$2.4B$2.4B$797M$2.5B$2.2B$2.3B$1.5B$913M$1.1B$1.9B$1.0B$1.1B$866M
FCF Margin %1.8%1.8%0.8%1.4%1.1%1.5%1.2%1.0%1.6%1.7%0.6%2.1%2.2%2.5%1.5%0.9%1.1%1.9%1.1%1.3%1.0%
Dividends Paid$491M$491M$494M$499M$525M$559M$573M$569M$577M$581M$577M$512M$460M$415M$353M$300M$274M$253M$200M$173M$144M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CAH Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Cash from Operations (CFO)$1.7B$1.8B$686M$973M$1.5B$2.9B($400M)($1.6B)
Capital Expenditures (CapEx)$264M$146M$131M$108M$232M$126M$99M$90M
Free Cash Flow (FCF)$1.4B$1.7B$555M$865M$1.3B$2.8B($499M)($1.7B)
FCF Margin %2.2%2.8%0.9%1.4%2.1%5.1%-0.9%-3.3%
Dividends Paid$120M$120M$122M$129M$120M$124M$122M$128M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CAH Balance Sheet History

Balance sheet2026-06-302026-06-302025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-30
Total Assets$57.3B$57.3B$53.1B$45.1B$43.3B$43.9B$44.5B$40.8B$41.0B$40.0B$40.1B$34.1B$30.1B$26.0B$25.8B$24.3B$22.8B$20.0B$25.1B$23.4B$23.2B
Cash & Cash Equivalents$4.9B$4.9B$3.9B$5.1B$4.1B$4.7B$3.4B$2.8B$2.5B$1.8B$6.9B$2.4B$4.6B$2.9B$1.9B$2.3B$1.9B$2.8B$1.2B$1.3B$1.3B
Total Liabilities$60.0B$60.0B$55.8B$48.3B$46.3B$44.6B$42.7B$39.0B$34.6B$33.9B$33.3B$27.6B$23.9B$19.6B$19.8B$18.0B$17.0B$14.7B$16.4B$15.7B$15.8B
Total Debt (Short + Long-Term)$9.1B$9.1B$8.7B$5.2B$4.8B$5.4B$6.3B$6.8B$8.0B$9.0B$10.4B$5.5B$5.5B$4.0B$3.9B$2.9B$2.5B$2.1B$3.6B$3.8B$3.5B
Total Shareholders' Equity($2.9B)($2.9B)($2.8B)($3.2B)($3.0B)($709M)$1.8B$1.8B$6.3B$6.1B$6.8B$6.6B$6.3B$6.4B$6.0B$6.2B$5.8B$5.3B$8.7B$7.7B$7.4B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CAH viewer.

CAH Metric Deep Dives

Other Companies in Health Care Distributors

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← CAGEAll “C” companiesCAI →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.